Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000446091

Medchemexpress LLC 2,5-Dihydroxybenzoic acid | 490-79-9 | MFCD00002476 | 154.12 | 1 G
SDP

Catalog No. 5000446091
Encompass_Preferred

2,5-Dihydroxybenzoic acid, also known as Gentisic acid, is a benzoic acid derivative and a potent inhibitor of fibroblast growth factors. It is recognized as a minor metabolite of aspirin and a constituent in various traditional liquors and herbal remedies. This compound serves as a critical lead in the discovery of new chemical classes of fibroblast growth factor inhibitors.

  • Derivative of benzoic acid
  • Potent inhibitor of fibroblast growth factors
  • Minor product of aspirin's metabolic breakdown
  • Component of traditional liquors and herbal remedies
  • Used as a lead to identify new fibroblast growth factor inhibitors
  • May interfere with assembly of signaling complexes for fibroblast growth factor-driven mitogenesis
  • Potential interest for treating cancer and angiogenesis-dependent diseases

Catalog No. 50-004-46091 Supplier Medchemexpress LLC Supplier No. HYW0011791G
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

2,5-Dihydroxybenzoic acid, also known as Gentisic acid, is a benzoic acid derivative and a potent inhibitor of fibroblast growth factors. It is recognized as a minor metabolite of aspirin and a constituent in various traditional liquors and herbal remedies. This compound serves as a critical lead in the discovery of new chemical classes of fibroblast growth factor inhibitors.

  • Derivative of benzoic acid
  • Potent inhibitor of fibroblast growth factors
  • Minor product of aspirin's metabolic breakdown
  • Component of traditional liquors and herbal remedies
  • Used as a lead to identify new fibroblast growth factor inhibitors
  • May interfere with assembly of signaling complexes for fibroblast growth factor-driven mitogenesis
  • Potential interest for treating cancer and angiogenesis-dependent diseases

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.